Integrated BioPharma extends revolving credit line to April 2027, enters $250K equipment note

INTEGRATED BIOPHARMA INC

Revolving line of credit extended to April 14, 2027; maximum principal remains $4,000,000.
New $250,000 Convertible Line of Credit Note (Daily SOFR) for equipment/vehicles replaces matured $500,000 note.
Interest on new note: Daily SOFR + 250 bps before conversion; after conversion, Daily SOFR or fixed rate at Bank's option.
Amendment fee of $4,000 and legal fees of $2,500 paid to PNC Bank as conditions to effectiveness.
Borrower reaffirms all security agreements, liens, and representations; no event of default exists.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.